Agalactosyl IgG induces liver fibrogenesis via Fc gamma receptor 3a on human hepatic stellate cells
The Journal of Pathology · 2024
DOI: 10.1002/path.6303 ↗At a glance
Journal article in The Journal of Pathology, 2024. Written by Cheng-Hsun Ho and 3 co-authors. Institution: Department of Medical Laboratory Science, College of Medical Science and Technology, I-Shou University, Kaohsiung, Taiwan. Major MEDLINE topics: Receptors, IgG, Hepatic Stellate Cells, Liver Cirrhosis, Immunoglobulin G. Cited 4 times so far (Crossref); 45 references. Funded by: National Science and Technology Council, Taiwan.
Abstract (original language)
The relevance of aberrant serum IgG N ‐glycosylation in liver fibrosis has been identified; however, its causal effect remains unclear. Because hepatic stellate cells (HSCs) contribute substantially to liver fibrosis, we investigated whether and through which mechanisms IgG N ‐glycosylation affects the fibrogenic properties of HSCs. Analysis of serum IgG 1 N ‐glycome from 151 patients with chronic hepatitis B or liver cirrhosis revealed a positive correlation between Ishak fibrosis grading and IgG 1 with agalactosyl N ‐glycoforms on the crystallizable fragment (Fc). Fc gamma receptor (FcγR) IIIa was observed in cultured human HSCs and HSCs in human liver tissues, and levels of FcγRIIIa in HSCs correlated with the severity of liver fibrosis. Additionally, agalactosyl IgG treatment caused HSCs to have a fibroblast‐like morphology, enhanced migration and invasion capabilities, and enhanced expression of the FcγRIIIa downstream tyrosine‐protein kinase SYK. Furthermore, agalactosyl IgG treatment increased fibrogenic factors in HSCs, including transforming growth factor (TGF)‐β1, total collagen, platelet‐derived growth factor subunit B and its receptors, pro‐collagen I‐α1, α‐smooth muscle actin, and matrix metalloproteinase 9. These effects were more pronounced in HSCs that stably expressed FCGR3A and were reduced in FCGR3A knockout cells. Agalactosyl IgG and TGF‐β1 each increased FCGR3A in HSCs. Furthermore, serum TGF‐β1 concentrations in patients were positively correlated with agalactosyl IgG 1 levels and liver fibrosis severity, indicating a positive feedback loop involving agalactosyl IgG, HSC‐FcγRIIIa, and TGF‐β1. In conclusion, agalactosyl IgG promotes fibrogenic characteristics in HSCs through FcγRIIIa. © 2024 The Pathological Society of Great Britain and Ireland.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medical Laboratory Science, College of Medical Science and Technology, I-Shou University, Kaohsiung, Taiwan.
- Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Center for Tropical Medicine and Infectious Disease Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
ORCID profiles: Cheng-Hsun Ho, Sheng-Fan Wang
Funding
- National Science and Technology Council, Taiwan
Cite
APA
Ho, C. H., Chang, T. T., Lin, H. C., & Wang, S. F. (2024). Agalactosyl IgG induces liver fibrogenesis via Fc gamma receptor 3a on human hepatic stellate cells. The Journal of Pathology. https://doi.org/10.1002/path.6303
Vancouver
Ho CH, Chang TT, Lin HC, Wang SF. Agalactosyl IgG induces liver fibrogenesis via Fc gamma receptor 3a on human hepatic stellate cells. The Journal of Pathology. 2024. doi:10.1002/path.6303
BibTeX
@article{Ho2024,
author = {Ho, Cheng-Hsun and Chang, Ting-Tsung and Lin, Hsien-Chang and Wang, Sheng-Fan},
title = {Agalactosyl IgG induces liver fibrogenesis via Fc gamma receptor 3a on human hepatic stellate cells},
journal = {The Journal of Pathology},
year = {2024},
doi = {10.1002/path.6303}
}
EUVIMED